BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26984608)

  • 21. Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C.
    Fecarotta S; Romano A; Della Casa R; Del Giudice E; Bruschini D; Mansi G; Bembi B; Dardis A; Fiumara A; Di Rocco M; Uziel G; Ardissone A; Roccatello D; Alpa M; Bertini E; D'Amico A; Dionisi-Vici C; Deodato F; Caviglia S; Federico A; Palmeri S; Gabrielli O; Santoro L; Filla A; Russo C; Parenti G; Andria G
    Orphanet J Rare Dis; 2015 Feb; 10():22. PubMed ID: 25888393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes in cerebellar and subcortical volumes in adult-onset Niemann-Pick disease type C patients treated with miglustat.
    Bowman EA; Walterfang M; Abel L; Desmond P; Fahey M; Velakoulis D
    J Neurol; 2015 Sep; 262(9):2106-14. PubMed ID: 26092521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series.
    Karimzadeh P; Tonekaboni SH; Ashrafi MR; Shafeghati Y; Rezayi A; Salehpour S; Ghofrani M; Taghdiri MM; Rahmanifar A; Zaman T; Aryani O; Shoar BN; Shiva F; Tavasoli A; Houshmand M
    J Child Neurol; 2013 Dec; 28(12):1599-606. PubMed ID: 23143717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Miglustat: a review of its use in Niemann-Pick disease type C.
    Lyseng-Williamson KA
    Drugs; 2014 Jan; 74(1):61-74. PubMed ID: 24338084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete recovery from psychosis upon miglustat treatment in a juvenile Niemann-Pick C patient.
    Szakszon K; Szegedi I; Magyar A; Oláh E; Andrejkovics M; Balla P; Lengyel A; Berényi E; Balogh I
    Eur J Paediatr Neurol; 2014 Jan; 18(1):75-8. PubMed ID: 24119781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy of miglustat in paediatric patients with Niemann-Pick disease type C.
    Chien YH; Peng SF; Yang CC; Lee NC; Tsai LK; Huang AC; Su SC; Tseng CC; Hwu WL
    J Inherit Metab Dis; 2013 Jan; 36(1):129-37. PubMed ID: 22476655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: A large retrospective observational study.
    Patterson MC; Garver WS; Giugliani R; Imrie J; Jahnova H; Meaney FJ; Nadjar Y; Vanier MT; Moneuse P; Morand O; Rosenberg D; Schwierin B; Héron B
    J Inherit Metab Dis; 2020 Sep; 43(5):1060-1069. PubMed ID: 32324281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
    Pastores GM; Barnett NL; Kolodny EH
    Clin Ther; 2005 Aug; 27(8):1215-27. PubMed ID: 16199246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann-Pick disease type C after therapy with miglustat.
    Fecarotta S; Amitrano M; Romano A; Della Casa R; Bruschini D; Astarita L; Parenti G; Andria G
    Am J Med Genet A; 2011 Mar; 155A(3):540-7. PubMed ID: 21344635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term therapy with miglustat and cognitive decline in the adult form of Niemann-Pick disease type C: a case report.
    Tozza S; Dubbioso R; Iodice R; Topa A; Esposito M; Ruggiero L; Spina E; De Rosa A; Saccà F; Santoro L; Manganelli F
    Neurol Sci; 2018 Jun; 39(6):1015-1019. PubMed ID: 29536386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary excretion and metabolism of miglustat and valproate in patients with Niemann-Pick type C1 disease: One- and two-dimensional solution-state (1)H NMR studies.
    Probert F; Ruiz-Rodado V; Zhang X; te Vruchte D; Claridge TD; Edgar M; Tocchio AZ; Lachmann RH; Platt FM; Grootveld M
    J Pharm Biomed Anal; 2016 Jan; 117():276-88. PubMed ID: 26397207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult form of Niemann-Pick type C with the variant biochemical phenotype on treatment with Miglustat.
    Jesús S; Cáceres-Redondo MT; Carrillo F; Cordones I; Escudero M; Macías-Vidal J; Coll MJ; Bautista J; Mir P
    Parkinsonism Relat Disord; 2013 Oct; 19(10):916-7. PubMed ID: 23791518
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective study.
    Freihuber C; Dahmani-Rabehi B; Brassier A; Broué P; Cances C; Chabrol B; Eyer D; Labarthe F; Latour P; Levade T; Pichard S; Sevin C; Vanier MT; Héron B
    Orphanet J Rare Dis; 2023 Jul; 18(1):204. PubMed ID: 37480097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and biochemical biomarkers for diagnosis and therapy monitorization of Niemann-Pick type C patients.
    Hammerschmidt TG; de Oliveira Schmitt Ribas G; Saraiva-Pereira ML; Bonatto MP; Kessler RG; Souza FTS; Trapp F; Michelin-Tirelli K; Burin MG; Giugliani R; Vargas CR
    Int J Dev Neurosci; 2018 May; 66():18-23. PubMed ID: 29197565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probable Miglustat-Induced Psychosis in a Child With Niemann-Pick Type C.
    Koç Yekedüz M; Öncül Ü; Köse E; Eminoğlu FT
    Clin Neuropharmacol; 2022 Jul-Aug 01; 45(4):107-109. PubMed ID: 35696615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of cataplexy in Niemann-Pick disease type C with the use of miglustat.
    Zarowski M; Steinborn B; Gurda B; Dvorakova L; Vlaskova H; Kothare SV
    Eur J Paediatr Neurol; 2011 Jan; 15(1):84-7. PubMed ID: 20207562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of structural neuroimaging biomarkers in a series of adult patients with Niemann-Pick type C under treatment.
    Masingue M; Adanyeguh I; Nadjar Y; Sedel F; Galanaud D; Mochel F
    Orphanet J Rare Dis; 2017 Feb; 12(1):22. PubMed ID: 28148276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of miglustat versus symptomatic therapy of Niemann-Pick disease type C.
    Gutić M; Milosavljević MN; Janković SM
    Int J Clin Pharm; 2022 Dec; 44(6):1442-1453. PubMed ID: 36243834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results from a 9-year Intensive Safety Surveillance Scheme (IS(3) ) in miglustat (Zavesca(®) )-treated patients.
    Brand M; Muller A; Alsop J; van Schaik IN; Bembi B; Hughes D
    Pharmacoepidemiol Drug Saf; 2015 Mar; 24(3):329-33. PubMed ID: 25656910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
    Maubert A; Hanon C; Metton JP
    Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.